Gamelin Erick — SEC insider filings

SEC reporting owner CIK 1950551. 18 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2022-11-16 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Acrivon Therapeutics, Inc. (ACRV)Chief Development Officer18—2 legs · 816 sh · $1,40717

Insider filings — Gamelin Erick

FiledFormIssuerReported transactionsSource
2026-11-194Acrivon Therapeutics, Inc. (ACRV)Sale (S): 416 @ $1.45EDGAR
2026-08-204Acrivon Therapeutics, Inc. (ACRV)Sale (S): 400 @ $2.01EDGAR
2026-05-204Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 38,584 @ $0EDGAR
2026-05-184Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 404 @ $1.92EDGAR
2026-03-034Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 94,946 (derivative) @ $0EDGAR
2026-02-184Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 471 @ $1.63EDGAR
2025-11-184Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 403 @ $2.24EDGAR
2025-08-184Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 403 @ $1.39EDGAR
2025-05-164Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 403 @ $1.14EDGAR
2025-03-044Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 78,078 (derivative) @ $0EDGAR
2025-02-194Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 469 @ $5.42EDGAR
2024-11-274Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 45,045 (derivative) @ $0EDGAR
2024-11-184Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 402 @ $7.92EDGAR
2024-08-164Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 402 @ $7.02EDGAR
2024-05-164Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 402 @ $8.36EDGAR
2024-02-164Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 468 @ $3.40EDGAR
2023-11-164Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 1,395 @ $5.08EDGAR
2022-11-164Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 20,030 @ $0 · Grant/award (A): 60,090 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1950551 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs